510.50
-1.00
(-0.20%)
At close: January 20 at 5:32:17 PM GMT+1
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 24 | 19 | 33 | 33 |
Avg. Estimate | 7.39B | 7.14B | 28.07B | 31.48B |
Low Estimate | 7.3B | 6.97B | 27.98B | 30.86B |
High Estimate | 7.43B | 7.39B | 28.2B | 32.28B |
Year Ago Sales | 6.55B | 6.35B | 25.1B | 28.07B |
Sales Growth (year/est) | 12.78% | 12.53% | 11.86% | 12.12% |
EPS Trend
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
MAST.VI | -- | -- | -- | -- |
S&P 500 | 9.34% | 11.25% | 14.04% | 13.55% |
Upgrades & Downgrades
Maintains | Citigroup: Buy to Buy | 1/14/2025 |
Downgrade | Seaport Global: Buy to Neutral | 1/14/2025 |
Maintains | Oppenheimer: Outperform to Outperform | 12/19/2024 |
Maintains | Morgan Stanley: Overweight to Overweight | 12/18/2024 |
Maintains | Jefferies: Buy to Buy | 12/9/2024 |
Maintains | Keefe, Bruyette & Woods: Outperform to Outperform | 12/9/2024 |